| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.002 |